IL151878A0 - Pharmaceutical compositions containing t3 - Google Patents
Pharmaceutical compositions containing t3Info
- Publication number
- IL151878A0 IL151878A0 IL15187801A IL15187801A IL151878A0 IL 151878 A0 IL151878 A0 IL 151878A0 IL 15187801 A IL15187801 A IL 15187801A IL 15187801 A IL15187801 A IL 15187801A IL 151878 A0 IL151878 A0 IL 151878A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- chf
- treat
- patient
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 4
- 206010019280 Heart failures Diseases 0.000 abstract 4
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicinal Preparation (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/533,227 US6288117B1 (en) | 2000-03-23 | 2000-03-23 | Method for treating congestive heart failure |
| PCT/US2001/008418 WO2001070218A1 (en) | 2000-03-23 | 2001-03-16 | Method for treating congestive heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL151878A0 true IL151878A0 (en) | 2003-04-10 |
Family
ID=24125041
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15187801A IL151878A0 (en) | 2000-03-23 | 2001-03-16 | Pharmaceutical compositions containing t3 |
| IL151878A IL151878A (en) | 2000-03-23 | 2002-09-23 | Pharmaceutical compositions containing t3 for treating congestive heart failure |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL151878A IL151878A (en) | 2000-03-23 | 2002-09-23 | Pharmaceutical compositions containing t3 for treating congestive heart failure |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6288117B1 (xx) |
| EP (1) | EP1292292B1 (xx) |
| JP (1) | JP2003527420A (xx) |
| AT (1) | ATE486594T1 (xx) |
| AU (2) | AU2001245785B2 (xx) |
| CA (1) | CA2403674C (xx) |
| DE (1) | DE60143390D1 (xx) |
| IL (2) | IL151878A0 (xx) |
| NO (1) | NO20024545L (xx) |
| NZ (1) | NZ522088A (xx) |
| WO (1) | WO2001070218A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040156893A1 (en) * | 2003-02-11 | 2004-08-12 | Irwin Klein | Method for treating hypothyroidism |
| GB0525461D0 (en) * | 2005-12-15 | 2006-01-25 | Archimedes Dev Ltd | Pharmaceutical compositions |
| US10695309B2 (en) | 2017-03-31 | 2020-06-30 | Western New England University | Sustained-release liothyronine formulations, method of preparation and method of use thereof |
| CN111632155B (zh) * | 2020-06-01 | 2023-01-24 | 西南大学 | 丝胶-钆pH响应性靶向肿瘤核磁共振造影剂的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3689669A (en) * | 1970-10-09 | 1972-09-05 | Univ Of North Carolina The | Antidepressant method and composition |
| US5158978A (en) | 1990-02-05 | 1992-10-27 | British Technology Group (U.S.A.) | Thyroid hormone treatment of acute cardiovascular compromise |
| NO924985L (no) * | 1991-12-30 | 1993-07-01 | Akzo Nv | Thyroaktiv blanding med vedvarende frigjoering |
-
2000
- 2000-03-23 US US09/533,227 patent/US6288117B1/en not_active Expired - Lifetime
-
2001
- 2001-03-16 WO PCT/US2001/008418 patent/WO2001070218A1/en active IP Right Grant
- 2001-03-16 EP EP01918743A patent/EP1292292B1/en not_active Expired - Lifetime
- 2001-03-16 NZ NZ522088A patent/NZ522088A/en unknown
- 2001-03-16 JP JP2001568416A patent/JP2003527420A/ja active Pending
- 2001-03-16 DE DE60143390T patent/DE60143390D1/de not_active Expired - Lifetime
- 2001-03-16 AU AU2001245785A patent/AU2001245785B2/en not_active Ceased
- 2001-03-16 IL IL15187801A patent/IL151878A0/xx active IP Right Grant
- 2001-03-16 AT AT01918743T patent/ATE486594T1/de not_active IP Right Cessation
- 2001-03-16 CA CA2403674A patent/CA2403674C/en not_active Expired - Fee Related
- 2001-03-16 AU AU4578501A patent/AU4578501A/xx active Pending
-
2002
- 2002-09-23 NO NO20024545A patent/NO20024545L/no not_active Application Discontinuation
- 2002-09-23 IL IL151878A patent/IL151878A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001070218A1 (en) | 2001-09-27 |
| NO20024545D0 (no) | 2002-09-23 |
| EP1292292A4 (en) | 2006-02-01 |
| EP1292292B1 (en) | 2010-11-03 |
| NZ522088A (en) | 2004-07-30 |
| IL151878A (en) | 2008-08-07 |
| ATE486594T1 (de) | 2010-11-15 |
| JP2003527420A (ja) | 2003-09-16 |
| EP1292292A1 (en) | 2003-03-19 |
| DE60143390D1 (de) | 2010-12-16 |
| AU4578501A (en) | 2001-10-03 |
| US6288117B1 (en) | 2001-09-11 |
| CA2403674C (en) | 2010-06-08 |
| CA2403674A1 (en) | 2001-09-27 |
| NO20024545L (no) | 2002-10-29 |
| AU2001245785B2 (en) | 2005-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03006855A (es) | Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion. | |
| MY127290A (en) | New use of flibanserin | |
| MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
| WO2003079979A3 (en) | Method for treating congestive heart failure | |
| CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
| IL145068A0 (en) | The use of glycine betaine to prepare a pharmaceutical composition | |
| RS44204A (xx) | Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1 | |
| DK1656131T3 (da) | Anvendelse af betain til behandling claudicatio intermittens | |
| IL151878A0 (en) | Pharmaceutical compositions containing t3 | |
| RS44304A (xx) | Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1 | |
| PL1648473T3 (pl) | Pojedyncza dawka szybko rozpuszczającej się azytromycyny | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| MXPA03005374A (es) | Carbazoles antitumorales. | |
| AU2368802A (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| SE0100873D0 (sv) | Method of treatment | |
| WO2002089848A3 (en) | Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes | |
| AU5434899A (en) | Cancer treatment | |
| MXPA03010920A (es) | Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia. | |
| AU8900498A (en) | Compounds and pharmaceutical compositions thereof for eliciting analgesic effects | |
| AU2002211217A1 (en) | Method of treating stroke | |
| NO20063319L (no) | Anvendelse av siramesin i behandlingen av cancer | |
| UA42427A (uk) | Спосіб корекції целюліту та/або локальних жирових відкладень |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |